Clinical Trial Update: Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia [Phase 1]

View source ↗

Summary

Phase I clinical trial of CG2001 in Chinese adult male participants with androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• CG2001

Snippet

Sponsor: Beijing Dayspring Pharmaceutical Technology Co., Ltd | Conditions: Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) | Phase 1 | Status: COMPLETED